Search

everythinglearnresearchcommunity

for

Search:↓

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Dupilumab effectively treated severe alopecia areata in a child.

The new delivery method for dutasteride is more effective and has fewer side effects.

Dupilumab may help treat hair loss and skin color loss in some patients with atopic dermatitis.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Deucravacitinib helped a man regrow hair significantly.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Guselkumab significantly improves quality of life for people with moderate to severe psoriasis.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

3D imaging effectively tracks skin changes in vitiligo treatment.

Microneedle-delivered polyglutamate effectively and safely improves hair growth in androgenetic alopecia.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Dupilumab can cause lupus-like symptoms, so patients need careful monitoring.

Ultrasound helps in safe fat transfer for buttock augmentation, but it's costly and time-consuming; the fat transfer technique is effective with high patient satisfaction.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.